Molecular cancer therapy: Cucurbitacin I (JSI-124) suppresses the expression of activator protein-1 via down regulation of its target gene, 5/May/2014, 5.47 am

Insights into the treatment of human Prostate cancer: Bicalutamide, an Androgen receptor antagonist, suppresses the expression of Interleukin-2 via down regulation of its target gene, 05/May/2014, 5.44 am
May 5, 2014
Mechanistic insights into enhanced generation of iPSCs: Withaferin, an arthritis drug, promotes reprogramming of differentiated cells to iPSCs, 5/May/2014, 5.55 am
May 5, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Molecular cancer therapy: Cucurbitacin I (JSI-124) suppresses the expression of activator protein-1 via down  regulation of its target  gene 5/May/2014, 5.47 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line ainfo@genomediscovery.org

Comments are closed.